Polycystic Ovarian Syndrome Treatment Market Size, Share & Trends Report

Polycystic Ovarian Syndrome Treatment Market Size, Share & Trends Analysis Report By Drug Class (Oral Contraceptives, Antiandrogens), By Surgery, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-2-68038-203-7
Number of Report Pages: 100
Format: PDF, Horizon Databook

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
  1.1. Market Segmentation and Scope
  1.2. Market Definitions
  1.3. Research Methodology
  1.3.1. Information Procurement
  1.3.2. Information or Data Analysis
  1.3.3. Market Formulation & Data Visualization
  1.3.4. Data Validation & Publishing
  1.4. Research Scope and Assumptions
  1.4.1. List of Data Sources
Chapter 2. Executive Summary
  2.1. Market Outlook
  2.2. Segment Outlook
  2.3. Competitive Insights
Chapter 3. Polycystic Ovarian Syndrome Treatment Market Variables, Trends, & Scope
  3.1. Market Introduction/Lineage Outlook
  3.2. Market Size and Growth Prospects (USD Billion)
  3.3. Market Dynamics
  3.3.1. Market Drivers Analysis
  3.3.2. Market Restraints Analysis
  3.4. Polycystic Ovarian Syndrome Treatment Market Analysis Tools
  3.4.1. Porter’s Analysis
  3.4.1.1. Bargaining power of the suppliers
  3.4.1.2. Bargaining power of the buyers
  3.4.1.3. Threats of substitution
  3.4.1.4. Threats from new entrants
  3.4.1.5. Competitive rivalry
  3.4.2. PESTEL Analysis
  3.4.2.1. Political landscape
  3.4.2.2. Economic and Social landscape
  3.4.2.3. Technological landscape
  3.4.2.4. Environmental landscape
  3.4.2.5. Legal landscape
Chapter 4. Polycystic Ovarian Syndrome Treatment Market: Drug Class Estimates & Trend Analysis
  4.1. Segment Dashboard
  4.2. Polycystic Ovarian Syndrome Treatment Market: Drug Class Movement Analysis, 2023 & 2030 (USD Billion)
  4.3. Oral Contraceptives
  4.3.1. Oral Contraceptives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  4.4. Antiandrogens
  4.4.1. Antiandrogens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  4.5. Insulin-sensitizing Agent
  4.5.1. Insulin-sensitizing Agent Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  4.6. Antidepressant
  4.6.1. Antidepressant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  4.7. Anti-obesity
  4.7.1. Anti-obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Polycystic Ovarian Syndrome Treatment Market: Surgery Estimates & Trend Analysis
  5.1. Segment Dashboard
  5.2. Polycystic Ovarian Syndrome Treatment Market: Surgery Movement Analysis, 2023 & 2030 (USD Billion)
  5.3. Ovarian Wedge Resection
  5.3.1. Ovarian Wedge Resection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  5.4. Laparoscopic Ovarian Drilling
  5.4.1. Laparoscopic Ovarian Drilling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Polycystic Ovarian Syndrome Treatment Market: Distribution Channel Estimates & Trend Analysis
  6.1. Segment Dashboard
  6.2. Polycystic Ovarian Syndrome Treatment Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Billion)
  6.3. Hospital Pharmacy
  6.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  6.4. Drug Store & Retail Pharmacy
  6.4.1. Drug Store & Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  6.5. Online Providers
  6.5.1. Online Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Polycystic Ovarian Syndrome Treatment Market: Regional Estimates & Trend Analysis
  7.1. Polycystic Ovarian Syndrome Treatment Market Share, By Region, 2023 & 2030 (USD Billion)
  7.2. North America
  7.2.1. North America Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.2.2. U.S.
  7.2.3. U.S. Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.2.4. Canada
  7.2.4.1. Canada Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.2.5. Mexico
  7.2.5.1. Mexico Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.3. Europe
  7.3.1. Europe Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.3.2. UK
  7.3.2.1. UK Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.3.3. Germany
  7.3.3.1. Germany Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.3.4. France
  7.3.4.1. France Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.4. Asia Pacific
  7.4.1. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.4.2. China
  7.4.2.1. China Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.4.3. Japan
  7.4.3.1. Japan Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.4.4. India
  7.4.4.1. India Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.4.5. South Korea
  7.4.5.1. South Korea Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.4.6. Australia
  7.4.6.1. Australia Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.5. Latin America
  7.5.1. Latin America Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.5.2. Brazil
  7.5.2.1. Brazil Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.6. Middle East and Africa
  7.6.1. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.6.2. Saudi Arabia
  7.6.2.1. Saudi Arabia Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.6.3. UAE
  7.6.3.1. UAE Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  7.6.4. South Africa
  7.6.4.1. South Africa Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. Competitive Landscape
  8.1. Recent Developments & Impact Analysis by Key Market Participants
  8.2. Company Categorization
  8.3. Company Heat Map Analysis
  8.4. Company Profiles
  8.4.1. AstraZeneca
  8.4.1.1. Participant’s Overview
  8.4.1.2. Financial Performance
  8.4.1.3. Product Benchmarking
  8.4.1.4. Recent Developments/ Strategic Initiatives
  8.4.2. Bayer AG
  8.4.2.1. Participant’s Overview
  8.4.2.2. Financial Performance
  8.4.2.3. Product Benchmarking
  8.4.2.4. Recent Developments/ Strategic Initiatives
  8.4.3. Merck KGaA.
  8.4.3.1. Participant’s Overview
  8.4.3.2. Financial Performance
  8.4.3.3. Product Benchmarking
  8.4.3.4. Recent Developments/ Strategic Initiatives
  8.4.4. Abbott
  8.4.4.1. Participant’s Overview
  8.4.4.2. Financial Performance
  8.4.4.3. Product Benchmarking
  8.4.4.4. Recent Developments/ Strategic Initiatives
  8.4.5. Pfizer, Inc
  8.4.5.1. Participant’s Overview
  8.4.5.2. Financial Performance
  8.4.5.3. Product Benchmarking
  8.4.5.4. Recent Developments/ Strategic Initiatives
  8.4.6. Sanofi
  8.4.6.1. Participant’s Overview
  8.4.6.2. Financial Performance
  8.4.6.3. Product Benchmarking
  8.4.6.4. Recent Developments/ Strategic Initiatives
  8.4.7. Bristol Myers Squibb Company
  8.4.7.1. Participant’s Overview
  8.4.7.2. Financial Performance
  8.4.7.3. Product Benchmarking
  8.4.7.4. Recent Developments/ Strategic Initiatives
  8.4.8. Teva Pharmaceutical Industries Ltd
  8.4.8.1. Participant’s Overview
  8.4.8.2. Financial Performance
  8.4.8.3. Product Benchmarking
  8.4.8.4. Recent Developments/ Strategic Initiatives
  8.4.9. Novartis AG
  8.4.9.1. Participant’s Overview
  8.4.9.2. Financial Performance
  8.4.9.3. Product Benchmarking
  8.4.9.4. Recent Developments/ Strategic Initiatives
  8.4.10. Ferring B.V.
  8.4.10.1. Participant’s Overview
  8.4.10.2. Financial Performance
  8.4.10.3. Product Benchmarking
  8.4.10.4. Recent Developments/ Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.